338 related articles for article (PubMed ID: 23396452)
1. ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4.
Mori J; Alrob OA; Wagg CS; Harris RA; Lopaschuk GD; Oudit GY
Am J Physiol Heart Circ Physiol; 2013 Apr; 304(8):H1103-13. PubMed ID: 23396452
[TBL] [Abstract][Full Text] [Related]
2. Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction.
Mori J; Basu R; McLean BA; Das SK; Zhang L; Patel VB; Wagg CS; Kassiri Z; Lopaschuk GD; Oudit GY
Circ Heart Fail; 2012 Jul; 5(4):493-503. PubMed ID: 22705769
[TBL] [Abstract][Full Text] [Related]
3. FoxO1 regulates myocardial glucose oxidation rates via transcriptional control of pyruvate dehydrogenase kinase 4 expression.
Gopal K; Saleme B; Al Batran R; Aburasayn H; Eshreif A; Ho KL; Ma WK; Almutairi M; Eaton F; Gandhi M; Park EA; Sutendra G; Ussher JR
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H479-H490. PubMed ID: 28687587
[TBL] [Abstract][Full Text] [Related]
4. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
Mori J; Zhang L; Oudit GY; Lopaschuk GD
J Mol Cell Cardiol; 2013 Oct; 63():98-106. PubMed ID: 23886814
[TBL] [Abstract][Full Text] [Related]
5. Coenzyme A-mediated degradation of pyruvate dehydrogenase kinase 4 promotes cardiac metabolic flexibility after high-fat feeding in mice.
Schafer C; Young ZT; Makarewich CA; Elnwasany A; Kinter C; Kinter M; Szweda LI
J Biol Chem; 2018 May; 293(18):6915-6924. PubMed ID: 29540486
[TBL] [Abstract][Full Text] [Related]
6. Adropin regulates cardiac energy metabolism and improves cardiac function and efficiency.
Altamimi TR; Gao S; Karwi QG; Fukushima A; Rawat S; Wagg CS; Zhang L; Lopaschuk GD
Metabolism; 2019 Sep; 98():37-48. PubMed ID: 31202835
[TBL] [Abstract][Full Text] [Related]
7. Cardiac metabolic compensation to hypertension requires lipoprotein lipase.
Yamashita H; Bharadwaj KG; Ikeda S; Park TS; Goldberg IJ
Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E705-13. PubMed ID: 18647880
[TBL] [Abstract][Full Text] [Related]
8. PGC-1
Gudiksen A; Pilegaard H
Physiol Rep; 2017 Apr; 5(7):. PubMed ID: 28400503
[TBL] [Abstract][Full Text] [Related]
9. Genetic activation of pyruvate dehydrogenase alters oxidative substrate selection to induce skeletal muscle insulin resistance.
Rahimi Y; Camporez JP; Petersen MC; Pesta D; Perry RJ; Jurczak MJ; Cline GW; Shulman GI
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16508-13. PubMed ID: 25368185
[TBL] [Abstract][Full Text] [Related]
10. The metabolic modulators, Etomoxir and NVP-LAB121, fail to reverse pressure overload induced heart failure in vivo.
Schwarzer M; Faerber G; Rueckauer T; Blum D; Pytel G; Mohr FW; Doenst T
Basic Res Cardiol; 2009 Sep; 104(5):547-57. PubMed ID: 19294446
[TBL] [Abstract][Full Text] [Related]
11. Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling.
Alrob OA; Sankaralingam S; Ma C; Wagg CS; Fillmore N; Jaswal JS; Sack MN; Lehner R; Gupta MP; Michelakis ED; Padwal RS; Johnstone DE; Sharma AM; Lopaschuk GD
Cardiovasc Res; 2014 Sep; 103(4):485-97. PubMed ID: 24966184
[TBL] [Abstract][Full Text] [Related]
12. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
[TBL] [Abstract][Full Text] [Related]
13. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
[TBL] [Abstract][Full Text] [Related]
14. Chronic inhibition of pyruvate dehydrogenase in heart triggers an adaptive metabolic response.
Chambers KT; Leone TC; Sambandam N; Kovacs A; Wagg CS; Lopaschuk GD; Finck BN; Kelly DP
J Biol Chem; 2011 Apr; 286(13):11155-62. PubMed ID: 21321124
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction.
Ding YQ; Zhang YH; Lu J; Li B; Yu WJ; Yue ZB; Hu YH; Wang PX; Li JY; Cai SD; Ye JT; Liu PQ
Acta Pharmacol Sin; 2021 Sep; 42(9):1422-1436. PubMed ID: 33247214
[TBL] [Abstract][Full Text] [Related]
16. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding.
Wright JJ; Kim J; Buchanan J; Boudina S; Sena S; Bakirtzi K; Ilkun O; Theobald HA; Cooksey RC; Kandror KV; Abel ED
Cardiovasc Res; 2009 May; 82(2):351-60. PubMed ID: 19147655
[TBL] [Abstract][Full Text] [Related]
18. Cardiac-Specific Deletion of the Pdha1 Gene Sensitizes Heart to Toxicological Actions of Ischemic Stress.
Sun W; Quan N; Wang L; Yang H; Chu D; Liu Q; Zhao X; Leng J; Li J
Toxicol Sci; 2016 May; 151(1):193-203. PubMed ID: 26884059
[TBL] [Abstract][Full Text] [Related]
19. Deletion of BCATm increases insulin-stimulated glucose oxidation in the heart.
Uddin GM; Karwi QG; Pherwani S; Gopal K; Wagg CS; Biswas D; Atnasious M; Wu Y; Wu G; Zhang L; Ho KL; Pulinilkunnil T; Ussher JR; Lopaschuk GD
Metabolism; 2021 Nov; 124():154871. PubMed ID: 34478752
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of pyruvate dehydrogenase activation by increased cardiac work.
Kobayashi K; Neely JR
J Mol Cell Cardiol; 1983 Jun; 15(6):369-82. PubMed ID: 6876186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
